Johnson & Johnson (JNJ) is the # 1 drug manufacturer in the industry as a whole according to Investors… JNJ received an overall rating of 65, which means that it holds over 65 percent of all shares. Johnson & Johnson also scored 86 points in the Drug Manufacturers – General Industry category, exceeding 86% of the Drug Manufacturers – General Inventory points. Pharmaceutical Manufacturers – General ranked 108th out of 148 industries.
What do these ratings mean?
Finding the best stocks to invest in can be difficult. There are thousands of options and it can be confusing, which is actually of great value. Investor Observer allows you to select one of eight unique metrics to view the top industries and best performing stocks in that industry A rating of 65 will result in a higher rating than 65% of all stocks.
These ratings are not only easy to understand, but also easy to compare stocks with each other. You can find the best stocks in the industry, or find the sector that has the highest GPA. Overall valuation is a combination of technical and fundamental factors that serves as a good starting point for analyzing stocks. Traders and investors with different goals may have different goals and will want to consider factors other than just the title before making any investment decisions.
What is happening with Johnson & Johnson stock today?
Johnson & Johnson (JNJ) traded at $ 166.91 at 2:48 pm on Thursday, June 10, up $ 1.25, or 0.75%, above its previous close of $ 165.66. Shares are trading in the range of $ 165.95 to $ 167.58 today. Volume is low today. To date, 3,330,705 shares have been sold, compared with an average of 6,835,336 shares.
Click here for the full Johnson & Johnson (JNJ) Stock Valuation Report.